Chaoju Eye Care (02219) announced that as of 20 November 2025, its total number of issued ordinary shares remained at 707,510,500. The report shows that share repurchases were conducted on 19 and 20 November 2025, each involving 120,000 shares for cancellation. The respective average repurchase prices were HKD 2.5651 on 19 November and HKD 2.5881 on 20 November.
According to the filing, the company’s share repurchase mandate was granted on 06 June 2025, authorizing up to 70,751,050 shares for repurchase. So far, 240,000 shares have been repurchased in total, representing approximately 0.034% of the issued shares as of the date of the mandate. A 30-day moratorium period after these repurchases ends on 20 December 2025, during which no new shares will be issued or transferred without prior approval from the Exchange.
Comments